Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET

Kahraman D, Scheffler M, Zander T, Nogova L, Lammertsma A, Boellaard R, Neumaier B, Ullrich R, Holstein A, Dietlein M, Wolf J, Kobe C

Journal: Journal of Nuclear Medicine, Vol 52, No 12, December 2011, doi:10.2967/jnumed.111.094458
Veröffentlichung: Dezember 2011